Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study - Concepedia

Concepedia

Publication | Closed Access

Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study

28

Citations

33

References

2003

Year

Majoie Hemelaar, Marius J. van der Mooren, Velja Mijatovic, Anneke A. Bouman, Charles P.T. Schijf, Maurice V. A. M. Kroeks, H. Franke, Peter Kenemans

Menopause The Journal of The North American Menopause Society

Abstract

Oral E2 and E2 + G, and to a lesser extent transdermal E2, decreased total and LDL cholesterol. Lp(a) was lowered only by the oral treatments.

References

	Year	Citations
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge William T. Friedewald, Robert I. Levy, Donald S. Fredrickson Clinical Chemistry Lipid AnalysisHyperlipidemiaDirect ProcedureMetabolic SyndromeBody Composition	1972	32.1K
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial JAMA	2002	15.7K
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women Stephen B. Hulley JAMA	1998	6.2K
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women Valery T. Miller JAMA Hormonal ContraceptiveHeart FailureGynecologyMenopausal Hormone TherapyPharmacotherapy	1995	2.3K
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials The Lancet Percutaneous Coronary InterventionHigh-risk GroupsPreventive MedicineCardiovascular EpidemiologyCardiovascular Disease	1996	1.6K
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis David M. Herrington, David M. Reboussin, K. Bridget Brosnihan, New England Journal of Medicine	2000	1.3K
Menopause and the Risk of Coronary Heart Disease in Women Graham A. Colditz, Walter C. Willett, Meir J. Stampfer, New England Journal of Medicine	1987	1.2K
A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease Francine Grodstein Annals of Internal Medicine	2000	1.1K
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial Valery T. Miller, John C. LaRosa, Vanessa M. Barnabei, JAMA	1995	605
Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women Kwang Kon Koh, Rita Mincemoyer, Minh Bui, New England Journal of Medicine	1997	376

Page 1